FAM111B knockdown attenuates tumorigenesis of ovarian cancer via the downregulation of MYC
These findings suggest that FAM111B may serve as a novel biomarker and potential therapeutic target in ovarian cancer.
Authors
- Guoyu Yu (ORCID: https://orcid.org/0000-0002-9425-6941)
- Fang Wei (ORCID: https://orcid.org/0000-0002-9771-184X)
- Lihong Zhang (ORCID: https://orcid.org/0000-0003-2738-6268)
- Qiuyun Guo
- Wanying Li (ORCID: https://orcid.org/0000-0002-0965-134X)
Institutions
- Hubei University of Medicine (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1186/s12885-025-14740-6
- Citations
- 1
- Primary Topic
- Galectins and Cancer Biology
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province